Triple-Negative Breast Cancer: effects of Tamoxifen in the lysosomal pathway

HISTAMINE MODULATES INTRATUMOR MICROBIOTA IN 4T1 TRIPLE NEGATIVE BREAST CANCER

Metronomic chemotherapy combining paclitaxel and a muscarinic agonist for triple negative breast cancer treatment

Targeting ID4 to Reprogram Triple-Negative Breast Cancer for Endocrine Therapy Sensitivity

Recovery of specific miRNAs in heparinized plasma obtained from HER2+ breast cancer patients who underwent neoadjuvant therapy protocol.

INVOLVEMENT OF RUNX1 IN TUMOR HETEROGENEITY ON TNBC CELL LINES

Insights into Androgen Receptor-Mediated Regulation of Acyl-CoA Synthetase 4 in Breast Cancer

Thyroid hormones modulate breast cancer metastasis formation by regulating the immune subset distribution in the lungs

Targeting RAC1: A Promising therapeutic approach for Triple-Negative Breast Cancer

Norcantharidin: a promising natural compound for the treatment triple negative breast cancer.